HIV prevention program for Latino male couples
Official title: Connecting Latinos En Pareja: a Couples-based HIV Prevention Intervention for Latino Male Couples
Run by University of Central Florida · NCT06131931 · Data updated 2026-11-12
This study is testing a program to help Latino male couples learn how to better protect themselves from HIV and see if it makes a difference over nine months.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | Men only |
| Enrollment | 400 (estimated) |
| Sponsor | University of Central Florida Academic / other |
| Locations | 1 site (Orlando, Florida) |
| Status | Recruiting |
| Started | June 21, 2023 |
| Main results expected | June 2028 |
| Study ends | June 2028 |
| Registry record updated | December 6, 2024 |
| Trial ID | NCT06131931 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include Latinx male couples who have been in a primary sexual relationship for at least three months and have reported unprotected anal sex.
✕Probably not a fit
Patients experiencing severe intimate partner violence or cognitive impairments that hinder informed consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This intervention aims to evaluate the effectiveness of Connecting Latinxs en Pareja (CLP), a four-session program designed to increase HIV protection among Latino male couples. Participants will be recruited from high HIV burden areas and randomly assigned to either the CLP intervention or a Wellness Promotion control group. The study will track changes in HIV protective behaviors over nine months, utilizing both biological markers and self-reported data. All sessions will be conducted remotely via Zoom, ensuring accessibility for participants.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce HIV transmission rates among Latino male couples.
How similar studies have gone: Previous studies targeting sexual minority Latinx men have shown promise, indicating potential for success with this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * at least 18 years * reside in the 50 local jurisdictions identified by the EHE initiative or 17 jurisdictions with most HIV diagnoses among Latinxs * identify as Latinx/Hispanic/Afro-Latinx or reports having a main partner who identifies as Latinx/Hispanic/Afro-Latin * report having a main/primary male partner operationalized as a man with whom he has a primary ongoing sexual relationship, for at least 3 months * at least one member of the dyad report three acts of unprotected of anal sex (with main or other partners) * able to speak English and/or Spanish Exclusion Criteria: Either partner: * reports severe intimate partner violence (IPV) within the dyad during the past year on the Revised Conflict Tactic Scale\[1-4\] * has a language or cognitive impairment that would prevent informed consent. Inclusion of dyads reporting severe IPV could pose dangers and ethical concerns and will be referred to domestic abuse organizations for screening and services. * adults unable to consent * pregnant women * prisoners * individuals who are not yet adults
Where it's running
-
University of Central Florida
Orlando, Florida, United States Recruiting
Study contacts
- Study coordinator: Omar Martinez, JD, MPH, MS
- Email: omar.martinez@ucf.edu
- Phone: 4072668742
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Project SHIELD 2.0: Police Education to Support Public Health in Kentucky
Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.
-
New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV
This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.
-
Bridge to Belonging: A Peer‑Led Program to Reduce Loneliness and Depression in older gay and bisexual men with HIV
This program tests a peer-delivered, manualized approach to help men aged 50+ with HIV connect to LGBTQ+-affirming elder services to see if it reduces loneliness and depressive symptoms.
-
HIV vaccine test in healthy adults using CH505 nanoparticles and mRNA boosters
This early-stage study will test the safety and immune responses of CH505 vaccine regimens in healthy adults to see if they can trigger HIV-specific immune protection.
-
Stigma-reducing program to help women who use drugs stay in HIV care
This test checks whether a stigma-reduction program helps women living with HIV who use drugs stay engaged in HIV care in Ukraine.
-
Platelets and HIV Reservoirs: A look at how platelets might harbor HIV in people living with HIV
This observational study tests whether HIV can be found inside platelets in adults with suppressed HIV on therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.